These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
314 related items for PubMed ID: 9247776
21. A comprehensive vision for intravenous iron therapy. Coyne DW. Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S14-20. PubMed ID: 19010257 [Abstract] [Full Text] [Related]
24. [Influence of iron metabolism on the efficacy of r-HuEPO (recombinant human erythropoietin) treatment of anemia in children on hemodialysis]. Pela I, Lavoratti GC, Materassi M, Burgio G, Bartolozzi G. Pediatr Med Chir; 1991 Dec; 13(5):475-7. PubMed ID: 1788107 [Abstract] [Full Text] [Related]
28. [Individual differences in the efficacy of Recormon in patients with terminal kidney failure. The role of iron deficiency]. Nikolaev AIu, Klepikov PV, Lashutin SV, Kondakhchan MA, Rogov VA, Trofimova EI. Ter Arkh; 1993 Dec; 65(6):45-8. PubMed ID: 8378849 [Abstract] [Full Text] [Related]
29. Greater potency of darbepoetin-α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients. Shoji S, Inaba M, Tomosugi N, Okuno S, Ichii M, Yamakawa T, Kurihara S. Eur J Haematol; 2013 Mar; 90(3):237-44. PubMed ID: 23281632 [Abstract] [Full Text] [Related]
30. Maintaining higher TSATs and other iron indices is beneficial in management of anemic hemodialysis patients. Besarab A, Dalton CL. Nephrol Nurs J; 2001 Aug; 28(4):429-34. PubMed ID: 12143465 [Abstract] [Full Text] [Related]
32. Comparative effects of erythropoietin with oral iron in peritoneal dialysis and hemodialysis patients. Raja R, Bloom E, Johnson R. Adv Perit Dial; 1993 Aug; 9():177-80. PubMed ID: 8105918 [Abstract] [Full Text] [Related]
34. Iron management during recombinant human erythropoietin therapy. Van Wyck DB. Am J Kidney Dis; 1989 Aug; 14(2 Suppl 1):9-13. PubMed ID: 2757026 [Abstract] [Full Text] [Related]
35. [Treatment of renal anemia with iron in hemodialysis patients in General Hospital Bjelovar]. Lovcić V, Vujić J, Basić-Jukić N, Janković RI, Kurtović I, Dzapo M, Lovcić P. Acta Med Croatica; 2011 Oct; 65 Suppl 3():45-8. PubMed ID: 23120815 [Abstract] [Full Text] [Related]
36. Effectiveness of erythropoiesis on supervised intradialytic oral iron and vitamin C therapy is correlated with Kt/V and patient weight. Tovbin D, Markowitz A, Mostoslavsky M, Landver R. Clin Nephrol; 2000 Apr; 53(4):276-82. PubMed ID: 10809415 [Abstract] [Full Text] [Related]
39. The utility of zinc protoporphyrin for predicting the need for intravenous iron therapy in hemodialysis patients. Fishbane S, Lynn RI. Am J Kidney Dis; 1995 Mar; 25(3):426-32. PubMed ID: 7872320 [Abstract] [Full Text] [Related]
40. [Can anemia be corrected in hemodialysis patients with thalassaemia minor? ]. Di Iorio B, Guastaferro P, Gironda A, Marano V, Morrongiello L, Cillo N, Zito B, Nigro F, Frieri A, Rubino R, Bellizzi V. G Ital Nefrol; 2002 Mar; 19(5):552-9. PubMed ID: 12439845 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]